Kimberly Clark Corp vs Altria Group Inc — how do they compare? Kimberly Clark Corp trades at $97.98 (market cap $32.51B), while Altria Group Inc trades at $71.75 (market cap $119.25B). The key difference: Altria Group Inc is far larger — about 3.7× Kimberly Clark Corp's market cap, and Altria Group Inc pays the higher dividend (6.22%). Which is the better fit depends on your goals — on Pluang, investors hold Kimberly Clark Corp for 93 Days and Altria Group Inc for 154 Days on average.
| KMB | MO | |
|---|---|---|
Market Cap | $32.51B | $119.25B |
Volume | 6,139,913 | 11,178,169 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $121.44 | $74.92 |
52-Week Low | $93.05 | $54.72 |
Typical Hold Time | 93 Days | 154 Days |
Enterprise Value | $38.07B | $141.46B |
Dividend Yield | 5.24% | 6.22% |
Signals from Pluang's Aura AI — not financial advice
Kimberly-Clark (KMB) trades at $98.02, up 1.6% on the day, showing modest recovery from recent weakness. The stock faces bearish technical signals with support at $96 and resistance at $98. Fundamentally, the company maintains strong profitability with 11.79% net margins and consistent dividend payments, though revenue declined to $16.45B in 2025. Recent executive transitions and the pending Kenvue acquisition create both uncertainty and strategic opportunity.
KMB offers a compelling dividend yield above 5% with 54 consecutive years of increases, but faces execution risks from the Kenvue integration. Analyst consensus targets $117.25 (19% upside) with mixed sentiment (32% buy, 58% hold). The stock presents value for income investors but requires careful monitoring of acquisition progress and cash flow sustainability.
Altria Group (MO) trades at $71.89, up 3.61% with a bullish technical signal from moving averages. The company maintains strong profitability with 39% net margins and generates robust operating cash flow of $9.29B, supporting its 6.6% dividend yield. Recent earnings show mixed results with one beat and two misses in the last four quarters. The stock trades below analyst consensus target of $69.71 despite negative shareholder equity of -$2.24B due to high debt levels.
MO offers income investors an attractive dividend yield but faces structural challenges including declining cigarette volumes and regulatory uncertainty. Analyst consensus remains positive with 61.5% buy ratings, though concerns persist about the sustainability of dividend payments given the company's negative equity position and competitive pressures in smoke-free alternatives.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →